Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.8B | 20.9B | 13.5B | 15.2B |
| Cost of revenue | 12.1B | 16.6B | 10.6B | 11.8B |
| Gross profit | 3.7B | 4.3B | 2.9B | 3.4B |
| Operating expense | ||||
| Research & development | 801M | 818M | 640M | 723M |
| Selling general and admin | 1.5B | 1.7B | 1.2B | 1.4B |
| Other operating expenses | 59M | 41M | — | 2M |
| Operating income | 1.4B | 1.9B | 1.2B | 1.3B |
| Non operating interest income | ||||
| Income | 32M | 126M | 145M | 135M |
| Expense | 42M | 354M | 85M | 158M |
| Other income expense | — | — | — | — |
| Pretax income | 1.6B | 1.7B | 1.2B | 1.3B |
| Tax provision | 344M | 283M | 275M | 296M |
| Net income | 1.3B | 1.4B | 972M | 1.0B |
| Basic EPS | 2.4 | 2.7 | 1.8 | 1.9 |
| Diluted EPS | 2.4 | 2.7 | 1.8 | 1.9 |
| Basic average shares | 535.7M | 534.8M | 534.0M | 533.7M |
| Diluted average shares | 539.8M | 540.1M | 539.1M | 539.3M |
| EBITDA | 1.7B | 2.1B | 1.3B | 1.5B |
| Net income from continuing op. | 1.6B | 1.7B | 1.2B | 1.3B |
| Minority interests | -9M | -7M | -6M | -12M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |